European Federation for Colposcopy (EFC), Brussels, Belgium.
J Low Genit Tract Dis. 2022 Jul 1;26(3):219-222. doi: 10.1097/LGT.0000000000000677. Epub 2022 May 6.
The aim of the study was to estimate the impact of COVID-19 pandemic on the practice of cervical cancer screening in European countries.
A 3 rounds e-survey was conducted among the 31 European Federation for Colposcopy member countries during 2020. Each representative was asked to answer to each questionnaire for their own country. Questionnaires were not anonymous. The first questionnaire was sent in April 2020 and second and third in June and December 2020, respectively.
Twenty five of the 31 European countries solicited responded. A total of 19 countries (70.4%) reported that screening for cervical cancer was suspended at least once during the 3 rounds of questionnaires. In addition, 11 countries reported stopping colposcopy and treatments for cervical precancerous lesions at least once during the 3 rounds of questionnaires. These situations evolved with time, with the highest rate of countries recommending suspension of screening, colposcopy, and treatments during the second round of the survey. At round 3, no country recommended screening, colposcopy, and treatment, and 12 countries (57.5%) reported normal screening was fully implemented.
Our results suggest massive disruption in cervical cancer screening programs across Europe resulting from COVID-19 pandemic. Increase in the incidence of cervical cancer is to be expected.
本研究旨在评估 COVID-19 大流行对欧洲国家宫颈癌筛查实践的影响。
2020 年期间，对 31 个欧洲阴道镜学会成员国家进行了三轮电子调查。每位代表均被要求代表其本国回答每个问卷。问卷不匿名。第一轮问卷于 2020 年 4 月发送，第二轮和第三轮分别于 2020 年 6 月和 12 月发送。
31 个欧洲国家中有 25 个国家应邀回复。共有 19 个国家（70.4%）报告在三轮问卷中至少有一次暂停了宫颈癌筛查。此外，11 个国家报告在三轮问卷中至少有一次停止了宫颈癌前病变的阴道镜检查和治疗。这些情况随着时间的推移而演变，在第二轮调查中，建议暂停筛查、阴道镜检查和治疗的国家比例最高。在第 3 轮，没有国家建议进行筛查、阴道镜检查和治疗，12 个国家（57.5%）报告全面实施了正常筛查。
我们的结果表明，COVID-19 大流行导致欧洲各地的宫颈癌筛查计划大规模中断。预计宫颈癌的发病率会上升。
Zotero 插件